| 000 | 01962nam a2200277Ia 4500 | ||
|---|---|---|---|
| 003 | MX-MdCICY | ||
| 005 | 20250625162454.0 | ||
| 040 | _cCICY | ||
| 090 | _aB-20744 | ||
| 245 | 1 | 0 | _aPolysaccharide-bioceramic composites for bone tissue engineering: A review |
| 490 | 0 | _vInternational Journal of Biological Macromolecules, 250, p.126237, 2023 | |
| 520 | 3 | _aLimitations associated with conventional bone substitutes such as autografts, increasing demand for bone grafts, and growing elderly population worldwide necessitate development of unique materials as bone graft substitutes. Bone tissue engineering (BTE)would ensure therapy advancement, efficiency, and cost-effective treatment modalities of bone defects. One way of engineering bone tissue scaffolds by mimicking natural bone tissue composed of organic and inorganic phases is to utilize polysaccharide-bioceramic hybrid composites. Polysaccharides are abundant in nature, and present in human body. Biominerals, like hydroxyapatite are present in natural bone and some of them possess osteoconductive and osteoinductive properties. Ion doped bioceramics could substitute protein-based biosignal molecules to achieve osteogenesis, vasculogenesis, angiogenesis, and stress shielding. This review is a systemic summary on properties, advantages, and limitations of polysaccharide-bioceramic/ion doped bioceramic composites along with their recent advancements in BTE. | |
| 650 | 1 | 4 | _aBONE SUBSTITUTES |
| 650 | 1 | 4 | _aBIOACTIVITY |
| 650 | 1 | 4 | _aCALCIUM PHOSPHATE |
| 650 | 1 | 4 | _aBIOGLASS |
| 650 | 1 | 4 | _aCALCIUM SILICATE |
| 700 | 1 | 2 | _aSivakumar, P. M. |
| 700 | 1 | 2 | _aYetisgin, A. A. |
| 700 | 1 | 2 | _aDemir, E. |
| 700 | 1 | 2 | _aSahin, S. B. |
| 700 | 1 | 2 | _aCetinel, S. |
| 856 | 4 | 0 |
_uhttps://drive.google.com/file/d/18SUf983vs8so1bWlZEOZyupPPP0tPbm2/view?usp=drivesdk _zPara ver el documento ingresa a Google con tu cuenta: @cicy.edu.mx |
| 942 |
_2Loc _cREF1 |
||
| 008 | 250602s9999 xx |||||s2 |||| ||und|d | ||
| 999 |
_c54825 _d54825 |
||